METASTATIC RENAL CANCER
Clinical trials for METASTATIC RENAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart scans aim to zap kidney cancer spots with precision
Disease control Recruiting nowThis study tests whether combining a special PET/CT scan (CAIX-targeted) with standard imaging can better find and treat cancer spots in people with advanced kidney cancer. About 70 adults with recurrent or metastatic clear cell renal cell carcinoma will receive standard drug the…
Matched conditions: METASTATIC RENAL CANCER
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New Triple-Drug cocktail aims to shrink Hard-to-Treat kidney tumors
Disease control Recruiting nowThis study is testing whether a combination of three drugs—sasanlimab, palbociclib, and axitinib—can shrink or control advanced kidney cancer that has spread. About 25 adults with clear cell or translocation renal cell carcinoma will receive the drugs and be monitored for tumor r…
Matched conditions: METASTATIC RENAL CANCER
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Precision radiation boosts kidney cancer treatment in new trial
Disease control Recruiting nowThis study looks at adding a precise type of radiation called SABR to standard drug therapy (targeted therapy and immunotherapy) for people with kidney cancer that has come back or spread. The goal is to see if this combination can help control the cancer longer than drugs alone.…
Matched conditions: METASTATIC RENAL CANCER
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 05, 2026 11:56 UTC